191 related articles for article (PubMed ID: 36949200)
1. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.
Jbara A; Lin KT; Stossel C; Siegfried Z; Shqerat H; Amar-Schwartz A; Elyada E; Mogilevsky M; Raitses-Gurevich M; Johnson JL; Yaron TM; Ovadia O; Jang GH; Danan-Gotthold M; Cantley LC; Levanon EY; Gallinger S; Krainer AR; Golan T; Karni R
Nature; 2023 May; 617(7959):147-153. PubMed ID: 36949200
[TBL] [Abstract][Full Text] [Related]
2. RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing.
Maurin M; Ranjouri M; Megino-Luque C; Newberg JY; Du D; Martin K; Miner RE; Prater MS; Wee DKB; Centeno B; Pruett-Miller SM; Stewart P; Fleming JB; Yu X; Bravo-Cordero JJ; Guccione E; Black MA; Mann KM
Nat Commun; 2023 Dec; 14(1):8444. PubMed ID: 38114498
[TBL] [Abstract][Full Text] [Related]
3. Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer.
Mochizuki Y; Funayama R; Shirota M; Kikukawa Y; Ohira M; Karasawa H; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Int J Cancer; 2021 Nov; 149(10):1787-1800. PubMed ID: 34346508
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ZFAS1 promotes laryngeal cancer progression through RBFOX2-mediated MENA alternative splicing.
Lu B; Li X; Miao W; Liu Q; Li R; Cui C; Gao Q; Lian R
Environ Toxicol; 2023 Mar; 38(3):522-533. PubMed ID: 36336961
[TBL] [Abstract][Full Text] [Related]
5. ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
Saulnier O; Guedri-Idjouadiene K; Aynaud MM; Chakraborty A; Bruyr J; Pineau J; O'Grady T; Mirabeau O; Grossetête S; Galvan B; Claes M; Al Oula Hassoun Z; Sadacca B; Laud K; Zaïdi S; Surdez D; Baulande S; Rambout X; Tirode F; Dutertre M; Delattre O; Dequiedt F
Nucleic Acids Res; 2021 May; 49(9):5038-5056. PubMed ID: 34009296
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing induces cytoplasmic localization of RBFOX2 protein in calcific tendinopathy.
Cho N; Kim JO; Lee S; Choi S; Kim J; Ko MS; Park SJ; Ji JH; Kim KK
Exp Mol Pathol; 2019 Aug; 109():36-41. PubMed ID: 31128090
[TBL] [Abstract][Full Text] [Related]
7. Myocardin regulates exon usage in smooth muscle cells through induction of splicing regulatory factors.
Liu L; Kryvokhyzha D; Rippe C; Jacob A; Borreguero-Muñoz A; Stenkula KG; Hansson O; Smith CWJ; Fisher SA; Swärd K
Cell Mol Life Sci; 2022 Aug; 79(8):459. PubMed ID: 35913515
[TBL] [Abstract][Full Text] [Related]
8. RBFOX2 protein domains and cellular activities.
Arya AD; Wilson DI; Baralle D; Raponi M
Biochem Soc Trans; 2014 Aug; 42(4):1180-3. PubMed ID: 25110022
[TBL] [Abstract][Full Text] [Related]
9. Alternative Splicing of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Is Regulated by RBFOX2 in Lymphoid Malignancies.
Cooper AM; Nutter CA; Kuyumcu-Martinez MN; Wright CW
Mol Cell Biol; 2022 May; 42(5):e0050321. PubMed ID: 35404107
[TBL] [Abstract][Full Text] [Related]
10. Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma.
Supadmanaba IGP; Mantini G; Randazzo O; Capula M; Muller IB; Cascioferro S; Diana P; Peters GJ; Giovannetti E
Epigenetics; 2022 Apr; 17(4):381-404. PubMed ID: 34057028
[TBL] [Abstract][Full Text] [Related]
11. RBFOX2 alters splicing outcome in distinct binding modes with multiple protein partners.
Zhou D; Couture S; Scott MS; Abou Elela S
Nucleic Acids Res; 2021 Aug; 49(14):8370-8383. PubMed ID: 34244793
[TBL] [Abstract][Full Text] [Related]
12. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
Gordon MA; Babbs B; Cochrane DR; Bitler BG; Richer JK
Mol Carcinog; 2019 Feb; 58(2):196-205. PubMed ID: 30294913
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA DKFZp434J0226 regulates the alternative splicing process through phosphorylation of SF3B6 in PDAC.
Li J; Tong H; Li D; Jiang Q; Zhang Y; Tang W; Jin D; Chen S; Qin X; Zhang S; Xue R
Mol Med; 2021 Aug; 27(1):95. PubMed ID: 34470609
[TBL] [Abstract][Full Text] [Related]
14. Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer.
Fici P; Gallerani G; Morel AP; Mercatali L; Ibrahim T; Scarpi E; Amadori D; Puisieux A; Rigaud M; Fabbri F
Oncotarget; 2017 Jan; 8(2):2423-2436. PubMed ID: 27911856
[TBL] [Abstract][Full Text] [Related]
15. Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression.
Kemper M; Schiecke A; Maar H; Nikulin S; Poloznikov A; Galatenko V; Tachezy M; Gebauer F; Lange T; Riecken K; Tonevitsky A; Aigner A; Izbicki J; Schumacher U; Wicklein D
J Exp Clin Cancer Res; 2021 Jun; 40(1):214. PubMed ID: 34174926
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer.
Arafat H; Lazar M; Salem K; Chipitsyna G; Gong Q; Pan TC; Zhang RZ; Yeo CJ; Chu ML
Surgery; 2011 Aug; 150(2):306-15. PubMed ID: 21719059
[TBL] [Abstract][Full Text] [Related]
17. RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis.
Luo CL; Xu XC; Liu CJ; He S; Chen JR; Feng YC; Liu SQ; Peng W; Zhou YQ; Liu YX; Wei PP; Li B; Mai HQ; Xia XJ; Bei JX
Adv Sci (Weinh); 2021 Aug; 8(16):e2004852. PubMed ID: 34180133
[TBL] [Abstract][Full Text] [Related]
18. HNRNPC impedes m
Huang XT; Li JH; Zhu XX; Huang CS; Gao ZX; Xu QC; Zhao W; Yin XY
Cancer Lett; 2021 Oct; 518():196-206. PubMed ID: 34271104
[TBL] [Abstract][Full Text] [Related]
19. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion.
Braeutigam C; Rago L; Rolke A; Waldmeier L; Christofori G; Winter J
Oncogene; 2014 Feb; 33(9):1082-92. PubMed ID: 23435423
[TBL] [Abstract][Full Text] [Related]
20. RBFOX2 is required for establishing RNA regulatory networks essential for heart development.
Verma SK; Deshmukh V; Thatcher K; Belanger KK; Rhyner AM; Meng S; Holcomb RJ; Bressan M; Martin JF; Cooke JP; Wythe JD; Widen SG; Lincoln J; Kuyumcu-Martinez MN
Nucleic Acids Res; 2022 Feb; 50(4):2270-2286. PubMed ID: 35137168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
